Trending Tech Politics Business Science Books Memes

Genome Web Media Bias

AI Generated News Bias (?): The source appears to be biased towards the biotechnology industry, as evidenced by the majority of headlines focusing on companies and products in the field ([0], [1], [2], [4], [8], [9], [10], [11], [12], [13], [14], [15]). This is further supported by the lack of headlines discussing any potential drawbacks of biotechnology ([5], [7]).



         
PrescriptiveSubjectiveSensationalBegging The QuestionOpinionatedGossipPessimisticPoliticalFearful12345678910

Genome Web Social Media Impact (?): 5


Genome Web Most Subjective Articles


People Seeking Polygenic Risk Scores May Struggle With Interpreting Result Reports

Twist Bioscience Shares Fall 20 Percent on Short Seller's Allegations of Fraud

Inscripta Lays Off Dozens, Closes Colorado Headquarters, San Diego Office

Single-Cell Sequencing Reveals Breast, Ovarian Cancer-Related Mutational Processes


Genome Web Most Pessimistic Articles


Guardant Health CRC Screening Results Spook Investors Despite Meeting Reimbursement Requirements

In Brief This Week: Biocept, Thermo Fisher, Biodesix, More

Twist Bioscience Shares Fall 20 Percent on Short Seller's Allegations of Fraud

In Brief This Week: Yourgene, Epigenomics, AnPac Bio-Medical, Biodesix, SomaLogic



Genome Web Most Prescriptive Articles


Novigenix Raises $14M in First Closing of Series B

New Standard BioTools Management Counting on Better Business Processes to Turn Firm Around

Variantyx Secures $20M Debt Financing to Support Precision Medicine in North America, Europe

Prenetics Authorizes $20M Share Buyback

Preliminary Earnings Roundup: NanoString Technologies, SomaLogic, Pacific Biosciences, More

Canaccord Initiates Coverage of Olink With Buy Rating

Top Five Articles on GenomeWeb Last Week: Invitae, IDT Deal; MGI Tech's Push Into US Market; More

Cardio Diagnostics Prepares for New Test Launches Following IPO


Genome Web Publishes More About


precision medicine

cancer institute

genetic testing

fisher scientific

california san francisco

molecular biology

gut microbiome

gene expression

Genome Web Most Similar Sources (?)


Trial Site News

Yahoo

businesswire.com

Epoch Times

marketbeat.com

Bloomberg


Genome Web Recent Articles

New Products Posted to GenomeWeb: Twist Bioscience, Centogene, Juno Diagnostics, Bio-Techne, More

business

Twist Bioscience and Centogene have launched three next-generation sequencing target enrichment panels to support rare disease and hereditary cancer research as well as diagnostics. All three panels were curated using the Centogene Biodatabank, which contains data or samples from 700,000 patients. The Twist Alliance CNTG Exome Panel relies on a core exome, mitochondrial genome, and other content for enhanced coverage of genes and variants related to rare diseases. The Twist Alliance CNTG Rare Disease Panel includes more than 2,500 rare disease-associated genes, such as for treatable diseases, early-onset childhood disorders, cardiac disorders, neurodgenerative diseases, skeletal abnormalities, and metabolic disorders. The Twist Alliance CNTG Hereditary Oncology Panel includes 72 cancer-associated genes, such as those for hereditary breast cancer, ...
Genome Web     Jan 14, 2023

Cochlear Implant Outcomes Linked to Type of Genetic Diagnosis for Childhood Hearing Loss

science

NEW YORK – In childhood-onset hearing loss that involves a genetic diagnosis, specific genes and variants may provide clues to everything from an individual's symptoms and hearing loss trajectory to their cochlear implant outcomes, new research suggests.
Genome Web     Jan 14, 2023

Element Biosciences Points to First Wave of Customer Data at JP Morgan Conference

science

They study looked at 10 families affected by an inherited retinal degradation phenotype, including one positive control that had been sequenced on Illumina's HiSeq X10. The previously unsequenced samples were run using 2×150 bp mode. The researchers sequenced one trio, for which the parents were "sequenced at a lower coverage so that all three samples could be combined on a single flow cell," the authors wrote. "High confidence variants were identified in five of the 10 pedigrees that we sequenced, including the positive control."
Genome Web     Jan 14, 2023

Survey Examines Professional Attitudes Toward Personal Genomic Data Ownership

science

While an individual having ownership of their genomic data is widely supported by professional stakeholders, concerns over the implications and extent of such ownership persist, according to a study appearing in the European Journal of Human Genetics. A growing body of research suggests that establishing patient genomic data ownership may help in responsibly balancing personal privacy with the advancement of medical science. To get additional perspective, investigators from the Commonwealth Scientific and Industrial Research Organization in Australia surveyed 117 genomic professionals — including geneticists, genetic counsellors, bioinformaticians, and researchers — about their views of people owning their own genomic data. They report that the majority of these professionals had favorable views on the matter, but that some ...
Genome Web     Jan 14, 2023

Study Highlights Limitations of Using Genetic Data for Evaluating COVID-19 Risk

science

While COVID-19 patients' genetics play a role in the severity of their disease, making the best use of genomic data in clinical care requires careful consideration of the molecular testing strategies employed, according to a study appearing this week in BMC Genomics. In addition to the environmental, clinical, and social factors involved in COVID-19 patient outcomes, it is increasingly clear that pathogen and host genetic factors are important, as well. Scientists from Comenius University in Slovakia analyzed whole-exome sequencing (WES) data from 27 people who died of SARS-CoV-2 infection, focusing on frequencies of DNA variants in genes previously associated with infection and the severity of COVID-19.
Genome Web     Jan 14, 2023

In Brief This Week: MDxHealth, Agilent Technologies, IsoPlexis, IntegraGen, More

health

NEW YORK – MDxHealth said this week that it expects preliminary 2022 revenues of about $37 million, which would be a 66 percent increase from $22.2 million in 2021. The company also expects a year-end cash balance of $15.5 million and reaffirmed its 2023 revenue guidance of between $65 million and $70 million.
Genome Web     Jan 14, 2023

People in the News at Quanterix, Arima Genomics, Theralink, Vizgen, DNAnexus, More

business

Quanterix has appointed Brian Blaser to is board of directors. Blaser has more than 25 years of senior leadership experience in the in vitro diagnostics industry, including 15 years at Abbott Laboratories where he was responsible for the global diagnostics organization. More recently, Blaser was senior advisor to McKinsey and is currently a director and chair of the audit committee for Rockley Photonics. He has also served in operations, finance, and engineering roles with Ortho Clinical Diagnostics (part of Johnson & Johnson), Eastman Kodak, and General Motors. Blaser holds an MBA from the Rochester Institute of Technology and a BS in mechanical engineering from the University of Dayton.
Genome Web     Jan 14, 2023

Oxford Team Reports Single-Cell Alternative Splicing Analysis Tool

science

An integrated alternative splicing analysis platform geared for single-cell RNA sequencing data generated from the plate- and droplet-based methods is presented in Nucleic Acids Research. While alternative splicing represents an important layer of transcriptional complexity underlying gene expression, the ability to study it at the single-cell level is hampered by a lack of computational tools. To help fill in this gap, University of Oxford scientists developed MARVEL, an R package for integrative single-cell alternative splicing and gene expression analysis. They benchmark MARVEL against existing tools and show its utility by analyzing publicly available datasets generated from the plate- and droplet-based library preparation methods derived from induced pluripotent stem cells differentiated into endoderm and cardiomyocytes, respectively.
Genome Web     Jan 14, 2023

FDA Grants EUA for Scope Molecular Laboratory SARS-CoV-2 Test for Serial Testing

science

The laboratory-developed test uses RT-PCR to detect SARS-CoV-2 RNA in anterior nasal swab specimens either collected by a healthcare provider or self-collected under the supervision of a healthcare provider. It may only be performed by Sublimity, Oregon-based Scope Molecular Laboratory, according to the FDA.
Genome Web     Jan 14, 2023

New MGH Technology Taps Microscopy for Single-Cell Sequencing in Spatial Context

tech

Named Image-seq, the method, which was described in a Nature Methods paper published in November 2022, deploys in vivo or in situ microscopy to help isolate intact and viable cells from specific locations within a tissue for downstream single-cell sequencing.
Genome Web     Jan 13, 2023

Cedars Sinai Team Develops Method for Quantitative Label-Free Proteomics Without LC Separation

science

Using the method, which was detailed in a study published last month in Analytical Chemistry, the researchers identified more than 2,000 proteins and quantified roughly 1,000 proteins in HeLa and 293T cell lysate samples with a throughput of around 300 samples per day.
Genome Web     Jan 13, 2023

Rebranded GeneDx Bets Future on Whole-Exome, Whole-Genome Sequencing in Pediatric Rare Disease

business

CHICAGO – In rebranding as GeneDx this week, the embattled company formerly known as Sema4 is making clear that its future is in whole-exome and whole-genome sequencing and related analysis to support precision medicine, particularly in pediatric rare diseases.
Genome Web     Jan 13, 2023